Skip to Main Content

Paper Details

Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial.
Eur Heart J Open
5
2023
HLHS, Hypoplastic left heart syndrome, Lomecel, MAPK, MSC, MSCs, RNAs, allogeneic medicinal signalling cells, exosomes, hypoplastic left heart syndrome, miR-215, miR-215-3p, miR-374b, patients, transplanted, transplanted MSC
Author NameAffiliation
James S TweddellHeart Institute, Cincinnati Children's Hospital Medical Center
Eric A Naioti
Michael E DavisGeorgia Institute of Technology & Emory University School of Medicine
  • 1 - 3

Datasets

Release 1.2